Difference between revisions of "WSI24-102-Case-1"

From MGH Learn Pathology
(Creating page)
 
(Added status template)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
 
{{ServiceRequestCase
 
{{ServiceRequestCase
|identifier=WSI24-102-Case-1
+
|subject=MGH
 
|intent=order
 
|intent=order
 +
|category=409073007
 +
|occurrenceDateTime=2024-05-07 12:00:00-07:00
 +
|basedOn=WSI24-102
 +
|priority=Routine
 
|code=apdidactic
 
|code=apdidactic
|category=409073007
+
|orderDetail=case
|subject=MGH
+
|authoredOn=2024-05-07 13:57:22.605937+00:00
 
|requester=Kx601
 
|requester=Kx601
 +
|locationCode=learn
 +
|sequence=1
 
|performer=Al603
 
|performer=Al603
|orderDetail=case
+
|bodySite=supraclavicular
|locationCode=learn
+
|reasonCode=76 man, hx of prostate cancer, new supraclavicular enlarged node
 +
|supportingInfo=Malignant, likely anaplastic thyroid carcinoma
 +
|identifier=WSI24-102-Case-1
 
|access=public
 
|access=public
 
|status=active
 
|status=active
 
|origin=CPOE
 
|origin=CPOE
|priority=Routine
 
|basedOn=WSI24-102
 
|requisition=
 
|reasonCode=History
 
|occurrenceDateTime=2024-05-07 12:00:00-07:00
 
|authoredOn=2024-05-07 13:57:22.605937+00:00
 
|sequence=1
 
|supportingInfo=Diagnosis
 
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=6ea3145c-eeba-48c4-b33d-6e38930bd7cb
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=1
 
|status=completed
 
|status=completed
|frames=1
 
 
|view=show
 
|view=show
|reasonCode=PAP NGYN
+
|identifier=6ea3145c-eeba-48c4-b33d-6e38930bd7cb
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=4fde02f1-dd53-47fc-843c-a6cb8dec8bd7
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=2
 
|status=completed
 
|status=completed
|frames=2
+
|reasonCode=H&E
 
|view=show
 
|view=show
|reasonCode=H&E
+
|identifier=4fde02f1-dd53-47fc-843c-a6cb8dec8bd7
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=4e870eb6-6a6f-4b76-9bc7-194a32452b41
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=3
 
|status=completed
 
|status=completed
|frames=3
 
 
|view=show
 
|view=show
|reasonCode=GATA3 B1
+
|identifier=4e870eb6-6a6f-4b76-9bc7-194a32452b41
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=d3eab19a-9db5-4168-b3e5-ba7671ca6f84
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=4
 
|status=completed
 
|status=completed
|frames=4
 
 
|view=show
 
|view=show
|reasonCode=PRQNT
+
|identifier=d3eab19a-9db5-4168-b3e5-ba7671ca6f84
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=fb9df141-3fef-4447-b5af-071d34366946
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=5
 
|status=completed
 
|status=completed
|frames=5
 
 
|view=show
 
|view=show
|reasonCode=Claudin 4 (T-C) B9
+
|identifier=fb9df141-3fef-4447-b5af-071d34366946
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=a5bb5df6-6889-4799-a482-71cfb52922bd
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=6
 
|status=completed
 
|status=completed
|frames=6
 
 
|view=show
 
|view=show
|reasonCode=PAX8 B4
+
|identifier=a5bb5df6-6889-4799-a482-71cfb52922bd
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=adaa3cab-fc17-43ee-b8f4-53e53fca0653
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=7
 
|status=completed
 
|status=completed
|frames=7
 
 
|view=show
 
|view=show
|reasonCode=TTF 1 B2
+
|identifier=adaa3cab-fc17-43ee-b8f4-53e53fca0653
|basedOn=WSI24-102-Case-1
 
 
}}
 
}}
 
 
{{Media
 
{{Media
|identifier=011b50a4-6874-456f-88e1-6065dc56ea84
 
 
|operator=Kx601
 
|operator=Kx601
 +
|frames=8
 
|status=completed
 
|status=completed
|frames=8
 
 
|view=show
 
|view=show
|reasonCode=Thyroglobulin B1
+
|identifier=011b50a4-6874-456f-88e1-6065dc56ea84
|basedOn=WSI24-102-Case-1
+
}}
 +
{{status
 +
|status=active
 +
|requester=Kx601
 +
|authoredOn=2024-05-07 13:57:22.605937+00:00
 
}}
 
}}

Latest revision as of 12:38, August 30, 2024

WSI24-102-Case-1
76 man, hx of prostate cancer, new supraclavicular enlarged node
Malignant, likely anaplastic thyroid carcinoma
May 7, 2024 3:00:00 PM